Upcoming Events

5th International HIV/Viral Hepatitis Co-Infection Meeting
Viral hepatitis elimination in Latin America and globally: How close are we?
20-21 July 2019 | Mexico City, Mexico

Similarly to earlier editions, this meeting will provide a unique opportunity to bring together a diversity of scientific, technical and community interests to discuss current opportunities and challenges for increased prevention, diagnosis and treatment of viral hepatitis in people living with HIV (and other populations).

Read more

Past events

  • TB 2018
    22 July 2018 | Amsterdam, the Netherlands

    TB 2018 will be an opportunity to highlight the key scientific challenges related to TB and TB/HIV research on prevention, diagnosis and treatment to set the stage for the UN General Assembly high-level meeting on TB. TB 2018 will focus on cutting-edge research gaps to address concrete service delivery issues, translating science into practice.

    Read more

  • STI 2018: Understanding and Addressing the HIV and STI Syndemics
    21-22 July 2018 | Amsterdam, the Netherlands

    STI 2018 will combine keynote presentations and roundtable discussions to provide a thorough investigation of the current state-of-the-art in STI prevention, treatment and care specifically in the context of the HIV epidemic.

    Read more

  • IAS session at INTEREST on “Comprehensive service delivery for key populations”
    29 May 2018 | Kigali, Rwanda

    Following a review of epidemiological data and normative guidance for key populations globally and in selected African countries, the session showcased clinical practice examples from healthcare workers who deliver quality, adapted, stigma-free healthcare services to key populations.

    Read more

  • 4th International HIV/Viral Hepatitis Co-Infection Meeting
    22-23 July 2017 | Paris, France

    The meeting focused on addressing the challenges of achieving elimination of hepatitis B and C in HIV-infected populations worldwide through reviewing the latest information on epidemiology, prevention, diagnostics and treatment.

    Read more

  • 3rd International HIV/Viral Hepatitis Co-Infection Meeting
    17 July 2016 | Durban, South Africa

    The recent development of highly effective antiviral therapy for HBV and HCV provides the opportunity to counter the rising burden of chronic liver disease among people living with HIV. Global antiretroviral therapy scale-up should limit HBV‐related liver disease, through dual antiviral activity.

    Read More